8-KThe WireRoutine
Shareholder Vote
Filed May 30, 2024 · 2y ago · Accession 0001664710-24-000045
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Keros Therapeutics, Inc.
- Ticker
- KROS
- CIK
- 1664710
- Form type
- 8-K
- Filing date
- May 30, 2024
- Report date
- May 30, 2024
- Document
- kros-20240530.htm
- Size
- 175 KB